» Articles » PMID: 35453352

Lyme Disease: A Role for Coenzyme Q10 Supplementation?

Overview
Date 2022 Apr 23
PMID 35453352
Authors
Affiliations
Soon will be listed here.
Abstract

Lyme disease results from a bacterial infection following a bite from an infected tick. Patients are initially treated with antibiotics; however, in cases where antibiotic treatment is delayed, or when patients do not respond to antibiotic treatment, fatigue may develop alongside problems affecting the nervous system, cardiovascular system, and joints. It is thought that most of the damage to these tissues results from the excessive inflammatory response of the host, involving a self-reinforcing cycle of mitochondrial dysfunction, oxidative stress and inflammation. In this article, we review the potential role of supplementary coenzyme Q10 (CoQ10) in mediating the pathogenic mechanism underlying Lyme disease, on the basis of its role in mitochondrial function, as well as its anti-inflammatory and antioxidant actions.

References
1.
Lopez-Lluch G, Del Pozo-Cruz J, Sanchez-Cuesta A, Cortes-Rodriguez A, Navas P . Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization. Nutrition. 2018; 57:133-140. DOI: 10.1016/j.nut.2018.05.020. View

2.
Heaton R, Heales S, Rahman K, Sexton D, Hargreaves I . The Effect of Cellular Coenzyme Q Deficiency on Lysosomal Acidification. J Clin Med. 2020; 9(6). PMC: 7355799. DOI: 10.3390/jcm9061923. View

3.
Lee B, Huang Y, Chen S, Lin P . Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease. Nutrition. 2011; 28(3):250-5. DOI: 10.1016/j.nut.2011.06.004. View

4.
Myhill S, Booth N, McLaren-Howard J . Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med. 2009; 2(1):1-16. PMC: 2680051. View

5.
Rebman A, Aucott J . Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease. Front Med (Lausanne). 2020; 7:57. PMC: 7052487. DOI: 10.3389/fmed.2020.00057. View